UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): September 22, 2004
CELLSTAR CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware | 0-22972 | 75-2479727 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
1730 Briercroft Court, Carrollton, Texas 75006
(Address of Principal Executive Offices) (Zip Code)
Registrants telephone number, including area code:
(972) 466-5000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 2 Financial Information
Item 2.02. Results of Operations and Financial Condition.
On September 22, 2004, CellStar Corporation held a conference call to discuss, among other things, expected financial results for its Asia Pacific operations for the third quarter of 2004 and to discuss its new strategies with respect to those operations. A copy of the transcript of the conference call is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
Section 9 Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(c) | Exhibits |
99.1 | Transcript of CellStar Corporation conference call held September 22, 2004. |
* * * * *
The information furnished in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly incorporated by specific itemized reference in such filing.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CELLSTAR CORPORATION | ||||
Date: September 24, 2004 | By: | /s/ Elaine Flud Rodriguez | ||
Name: | Elaine Flud Rodriguez | |||
Title: | Senior Vice President and General Counsel |
3
EXHIBIT INDEX
Number |
Description of Exhibit | |
99.1 | Transcript of CellStar Corporation conference call held September 22, 2004 |
4